Results
1140
Most Popular Stocks on the market
1140 companies
Alterola Biotech
Market Cap: US$296.3k
A pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules.
ABTI
US$0.0002
7D
0%
1Y
-95.0%
IMAC Holdings
Market Cap: US$265.3k
Through its subsidiary, Ignite Proteomics LLC, provides proteomic product and precision medicine services based on activated protein analysis for the treatment of cancer in the United States.
BACK
US$0.074
7D
2.2%
1Y
-93.6%
RegeneRx Biopharmaceuticals
Market Cap: US$242.9k
A biopharmaceutical company, focuses on the development of therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair, and regeneration.
RGRX
US$0.16
7D
0%
1Y
11,400.0%
Panbela Therapeutics
Market Cap: US$242.7k
A clinical-stage biopharmaceutical company, engages in the development of disruptive therapeutics for the treatment of patients with urgent unmet medical needs.
PBLA
US$0.05
7D
-0.2%
1Y
-84.8%
CNBX Pharmaceuticals
Market Cap: US$226.0k
A clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer.
CNBX
US$0.00035
7D
16.7%
1Y
-94.7%
Synairgen
Market Cap: US$220.5k
Synairgen plc discovers and develops drugs for respiratory diseases.
SYGG.F
US$0.0002
7D
100.0%
1Y
-99.5%
Beroni Group
Market Cap: US$217.5k
Develops and sells smoking control products, air purifier, water filter, healthcare products and supplements, cell therapies, stem-cell based cosmetics, and viral diagnostic kits in China.
BNIG.F
US$0.0064
7D
0%
1Y
n/a
Vincerx Pharma
Market Cap: US$209.4k
Operates as a clinical-stage biopharmaceutical company that develops differentiated and novel therapies to address the unmet medical needs of patients with cancer in the United States.
VINC
US$0.049
7D
22.6%
1Y
-99.6%
Greater Cannabis Company
Market Cap: US$202.5k
Engages in the development and commercialization of cannabinoid therapeutics.
GCAN
US$0.0003
7D
87.5%
1Y
-40.0%
Tian'an Pharmaceutical
Market Cap: US$196.1k
Develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China.
TNPH
US$0.0024
7D
0%
1Y
n/a
PAO Group
Market Cap: US$191.0k
Focuses on alternative patient care treatments.
PAOG
US$0.0001
7D
-50.0%
1Y
-75.0%
Allstar Health Brands
Market Cap: US$179.8k
A specialty health care products company, focuses on enhancing health and quality of life by offering select medicines, natural nutritional supplements, and over the counter remedies in the Americas.
ALST
US$0.00055
7D
-8.3%
1Y
-21.4%
GNCC Capital
Market Cap: US$174.1k
Through its subsidiary, BioCann Pharma S.A.S., produces and sells cannabis CBD pharmaceutical grade oils.
GNCP
US$0.000001
7D
0%
1Y
0%
ViaDerma
Market Cap: US$123.4k
Operates as a specialty pharmaceutical company in the United States.
VDRM
US$0.0002
7D
0%
1Y
-96.3%
Ampio Pharmaceuticals
Market Cap: US$121.7k
A biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States.
AMPE
US$0.0027
7D
0%
1Y
22.7%
Endonovo Therapeutics
Market Cap: US$120.7k
A biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine.
ENDV
US$0.0001
7D
0%
1Y
-92.3%
Woodbrook Group Holdings
Market Cap: US$99.4k
Provides investment and strategic planning advisory services.
WDBG
US$0.0003
7D
0%
1Y
-99.5%
Medicine Man Technologies
Market Cap: US$85.6k
Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico.
SHWZ
US$0.001
7D
-50.0%
1Y
-99.1%
Zhengduozhe Technology
Market Cap: US$84.1k
Zhengduozhe Technology, Inc, doing business as DAKOTA Life Sciences, operates as a biopharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceuticals designed to prevent and treat serious conditions arising in hospital and community settings.
ZDZT
US$1.92
7D
0%
1Y
-68.0%
GB Sciences
Market Cap: US$81.4k
A plant-based research and biopharmaceutical drug development company.
GBLX
US$0.0002
7D
100.0%
1Y
-96.7%
Syros Pharmaceuticals
Market Cap: US$79.2k
A biopharmaceutical company, focuses on the development of treatment for hematologic malignancies.
SYRS
US$0.0001
7D
-83.3%
1Y
-100.0%
MabCure
Market Cap: US$78.1k
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer.
MBCI
US$0.0001
7D
0%
1Y
n/a
Nouveau Life Pharmaceuticals
Market Cap: US$66.6k
A development stage company, engages in the development of nutraceuticals products.
NOUV
US$0.000001
7D
0%
1Y
-99.0%
U.S. Stem Cell
Market Cap: US$66.2k
A biotechnology company, engages in the discovery, development, and commercialization of autologous cellular therapies for the treatment of chronic and acute heart damage, and vascular and autoimmune diseases in the United States.
USRM
US$0.0001
7D
0%
1Y
9,900.0%
Affymax
Market Cap: US$59.6k
Does not have significant operations.
AFFY
US$0.0009
7D
12.5%
1Y
28.6%
Immunotech Laboratories
Market Cap: US$57.5k
Develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders.
IMMB
US$0.0001
7D
0%
1Y
n/a
Bright Green
Market Cap: US$57.3k
Produces and exports legal cannabis, cannabis extracts, and tetrahydrocannabinol in the United States.
BGXX.Q
US$0.0008
7D
-75.0%
1Y
-98.5%
Hero Technologies
Market Cap: US$56.4k
Operates as an early-stage cannabis company.
HENC
US$0.0001
7D
0%
1Y
9,900.0%
Mera Pharmaceuticals
Market Cap: US$53.7k
Focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology.
MRPI
US$0.0001
7D
0%
1Y
n/a
Cannonau
Market Cap: US$48.4k
Engages in the provision of cannabidiol based products.
CNNC
US$0.0002
7D
-33.3%
1Y
-90.0%
Medican Enterprises
Market Cap: US$46.5k
A bio-pharmaceutical company, focuses on pursuing business opportunities in the medical and recreational marijuana sector.
MDCN
US$0.000001
7D
0%
1Y
0%
Plandaí Biotechnology
Market Cap: US$44.9k
Focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries.
PLPL
US$0.0001
7D
9,900.0%
1Y
0%
Itoco
Market Cap: US$42.8k
Engages in the processing, production, and distribution of medical cannabis products.
ITMC
US$0.0001
7D
0%
1Y
-96.8%
Emergent Health
Market Cap: US$42.7k
Develops and sells regenerative medicine, neutraceuticals, and phytonutritionals.
EMGE
US$0.0001
7D
0%
1Y
-92.3%
Oncology Pharma
Market Cap: US$42.5k
An oncology company, develops, manufactures, and commercializes therapeutics.
ONPH
US$0.0011
7D
174.3%
1Y
109,900.0%
Sunset Island Group
Market Cap: US$34.4k
Through its subsidiary, VBF Brands, engages in the cultivation of medical cannabis in California, the United States.
SIGO
US$0.0001
7D
0%
1Y
9,900.0%